Chemotherapy, radiotherapy and immunotherapy for cancer - MBS item (15990)

The following MBS item is included in this clinical category.

15990
Proton beam dosimetry, and proton-photon comparative plan reporting, to assess eligibility for proton beam therapy via the Medical Treatment Overseas Program if: (a) proton planning is required to calculate dose to single or multiple-target structures and requires a dose-volume histogram to complete the planning process; and (b) the proton planning process optimises the differential between target dose, organs at risk, and normal tissue dose, based on review and assessment by a radiation oncologist; and (c) all relevant gross tumour volumes, clinical target volumes and organs at risk are rendered as volumes and nominated with planning dose objectives; and (d) organs at risk are nominated as planning dose constraints; and (e) dose calculations and dose-volume histograms are generated in an inverse planned process, using a specialised calculation algorithm, with prescription and plan details approved and recorded with the plan; and (f) a three-dimensional or four-dimensional image volume dataset is used for the relevant region to be planned and verified; and (g) the final proton dosimetry plan is: (i) validated by both the appropriately qualified radiation therapist and medical physicist, using robust quality assurance processes; and (ii) approved by the radiation oncologist, ensuring the plan is clinically realistic and assessed to be robust to expected uncertainties encountered in proton beam therapy; and (h) a proton-photon comparative plan report is generated; and (i) the service is bulk-billed